Medtronic plc (MDTC34) — Cash Flow Reinvestment Rate
Medtronic plc (MDTC34) has a Cash Flow Reinvestment Rate of 0.20x as of April 2026, reinvesting R$518.00 Million (capex R$488.00 Million plus investments R$-30.00 Million) from operating cash flow of R$2.57 Billion. See how much free cash does Medtronic plc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medtronic plc Cash Flow Reinvestment Rate (2019–2026)
Historical reinvestment intensity for Medtronic plc across 8 annual periods. For the full cash flow conversion analysis, see MDTC34 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Medtronic plc (2019–2026)
Year-by-year capital reinvestment analysis for Medtronic plc. See MDTC34 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (BRL) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.34x | R$2.52 Billion | R$7.33 Billion | R$1.90 Billion | ▼ -36.1% |
| 2025 | 0.54x | R$3.80 Billion | R$7.04 Billion | R$1.86 Billion | ▼ -7.5% |
| 2024 | 0.58x | R$3.95 Billion | R$6.79 Billion | R$1.59 Billion | ▼ -29.0% |
| 2023 | 0.82x | R$4.95 Billion | R$6.04 Billion | R$1.46 Billion | ▲ +286.6% |
| 2022 | 0.21x | R$1.56 Billion | R$7.35 Billion | R$1.37 Billion | ▼ -27.2% |
| 2021 | 0.29x | R$1.82 Billion | R$6.24 Billion | R$1.35 Billion | ▼ -21.3% |
| 2020 | 0.37x | R$2.68 Billion | R$7.23 Billion | R$1.21 Billion | ▼ -21.0% |
| 2019 | 0.47x | R$3.29 Billion | R$7.01 Billion | R$1.13 Billion | — |